Why we are different
The LatticePoint team has over 40 years of pharmaceutical and biotechnology industry experience. Led by former industry market access leaders and a high-caliber team with significant experience in the sciences, licensing, M&A due diligence and integration, venture capital and international affiliate operations, we have a depth of experience not seen in most consultancies. We can efficiently and accurately define a medicine’s value and have our team ready to create the right strategy whether you are raising capital, in-licensing, launching or preparing for competition.
Global negotiation experience
At LatticePoint, we have in-country experience working with, and on behalf of, our clients who require on-the-ground assistance. Our multilingual staff of native German, French, Italian, Spanish, Portuguese and English speakers is experienced at handling negotiations in many key countries while keeping an eye on cross-border implications. We engage with payers, providers, hospitals, HTA bodies and EMA for early access, give feedback on clinical program design, and create and execute in-country reimbursement strategy negotiations in key markets around the world. We retain a Global Payer Panel for market research interviews.